We first test the ability of individual CSF biomarkers including t-tau, Aβ42, p-tau, and two ratios (t-tau/Aβ42 and p-tau/Aβ42) for predicting the conversion from MCI to probable AD, and the results are summarized in Table 4. The gene discussed is MAPT; the disease is Alzheimer disease.